Learn more about Angelo and his recap of 2022 at GenomSys and his outlook for 2023 for himself and the company through the following quick questions:
Hi Angelo and a happy New Year to you. Starting of easy, which fun-fact did you learn this year?
For me, particularly, was the inclusion of the Trio analysis into our GenomSys Variant Analyzer. This part of genomic testing was completely unknown territory for me as a software engineer. But by combining efforts from the bioinformatic team, backend and frontend developers, we made it possible to achieve it, and I learned a lot about how much Trio analysis can help in genomic testing to improve patients’ lives.
What was your most outstanding achievement at GenomSys in 2022?
I think it’s our first clients that we got last year. Their interest in and use of our solutions is a clear sign that we are moving in the right way. And that we develop something of apparent benefit for the genomic field.
What was the most important thing you learned in 2022?
As I oversee the development of GenomSys Variant Analyzer, which includes a lot of project management, I must say that I learned various new tactics and skills that help me to manage the projects in the right way and ultimately reach the set goals in time.
What are your expectations for you and/or GenomSys for 2023?
I hope more happy clients, for actual and future products.
If you have any further questions for Angelo or about GenomSys, please feel free to contact us.
